Does baclofen activate GABA receptors, and if so which subtype does it target?

Baclofen Mechanism of Action: GABA Receptor Activation

Baclofen is a selective agonist of GABA_B receptors, not GABA_A receptors, and works by activating these metabotropic G-protein coupled receptors both presynaptically and postsynaptically in the central nervous system. 1, 2

Receptor Subtype Specificity

• Baclofen is a lipophilic γ-aminobutyric acid (GABA) derivative that exhibits strong intrinsic activity and high affinity specifically for GABA_B receptors, which are metabotropic G-protein coupled receptors (GPCRs). 2, 3

• The drug is bicuculline-insensitive, meaning it does not activate GABA_A receptors (the ionotropic ligand-gated chloride channels that are targeted by benzodiazepines). 4, 5

• Baclofen remains the only FDA-approved GABA_B receptor agonist and received approval before the GABA_B receptor was even discovered, initially being designed as a more brain-penetrant version of GABA for epilepsy treatment. 6

Dual Mechanism: Presynaptic and Postsynaptic Effects

Presynaptic inhibition:

• Baclofen significantly reduces the frequency of miniature excitatory postsynaptic currents, indicating strong presynaptic inhibition by decreasing neurotransmitter release from primary afferent terminals. 2, 4

• GABA_B receptors are present in high concentrations in laminae I-IV of the dorsal horn of the spinal cord, where they modulate sensory transmission. 4

Postsynaptic effects:

• Baclofen induces outward currents in ventral horn neurons through direct postsynaptic depression mediated by G-protein-activated potassium channels. 2

• These postsynaptic effects persist in the presence of tetrodotoxin and glutamate receptor antagonists but are blocked by intracellular potassium channel blockers and G-protein inhibitors, confirming the G-protein coupled mechanism. 2

Clinical Pharmacology Context

• The FDA label acknowledges that while baclofen is an analog of GABA, there is no conclusive evidence that actions on GABA systems alone fully explain its clinical effects, though its GABA_B receptor activity is the primary mechanism. 1

• The drug's ability to inhibit both monosynaptic and polysynaptic reflexes at the spinal level occurs through hyperpolarization of afferent terminals, with possible supraspinal contributions. 1

Important Clinical Caveat

• Abrupt discontinuation of baclofen, particularly intrathecal formulations, can cause life-threatening withdrawal including hallucinations, seizures, fever, autonomic instability, rhabdomyolysis, and multiorgan failure due to the chronic modulation of GABA_B receptor activity. 7, 8